179116-05-3

• 

• Basic information

  1. Product Name: Carbamic acid, (3-hydroxy-1,2-dimethylpropyl)-, 1,1-dimethylethyl ester,
  2. Synonyms:
  3. CAS NO:179116-05-3
  4. Molecular Formula: C10H21NO3
  5. Molecular Weight: 0
  6. EINECS: N/A
  7. Product Categories: N-BOC
  8. Mol File: 179116-05-3.mol
  9. Article Data: 3

• Chemical Properties

  1. Melting Point: N/A
  2. Boiling Point: N/A
  3. Flash Point: N/A
  4. Appearance: /
  5. Density: N/A
  6. Refractive Index: N/A
  7. Storage Temp.: N/A
  8. Solubility: N/A
  9. CAS DataBase Reference: Carbamic acid, (3-hydroxy-1,2-dimethylpropyl)-, 1,1-dimethylethyl ester,(CAS DataBase Reference)
  10. NIST Chemistry Reference: Carbamic acid, (3-hydroxy-1,2-dimethylpropyl)-, 1,1-dimethylethyl ester,(179116-05-3)
  11. EPA Substance Registry System: Carbamic acid, (3-hydroxy-1,2-dimethylpropyl)-, 1,1-dimethylethyl ester,(179116-05-3)

• Safety Data

  1. Hazard Codes: N/A
  2. Statements: N/A
  3. Safety Statements: N/A
  4. WGK Germany:
  5. RTECS:
  6. HazardClass: N/A
  7. PackingGroup: N/A
  8. Hazardous Substances Data: 179116-05-3(Hazardous Substances Data)

• Suppliers
• Usage
• Upstream product
• Downstream Products
• Article

179116-05-3 Suppliers

Recommended suppliersmore

• Product
• FOB Price
• Min.Order
• Supply Ability
• Supplier
• Contact Supplier

179116-05-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 179116-05-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,1,1 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 179116-05:
(8*1)+(7*7)+(6*9)+(5*1)+(4*1)+(3*6)+(2*0)+(1*5)=143
143 % 10 = 3
So 179116-05-3 is a valid CAS Registry Number.

179116-05-3Upstream product

• 609-14-3 2-acetylpropanoic acid ethyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 403712-71-0 C₁₀H₁₉NO₃ 

179116-05-3Downstream Products

179116-05-3Relevant articles and documents

INHIBITORS OF LEUCINE RICH REPEAT KINASE 2

-

, (2019/02/02)

The present invention relates to novel compounds that inhibit LRRK2 kinase activity, to processes for their preparation, to compositions containing them and to their use in the treatment of or prevention of diseases associated with or characterized by LRRK2 kinase activity, for example Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS).

Double bond isomerization/enantioselective aza-petasis-ferrier rearrangement sequence as an efficient entry to anti- and enantioenriched β-Amino Aldehydes

Terada, Masahiro,Toda, Yasunori

supporting information; experimental part, p. 6354 - 6355 (2009/09/26)

-

Post a RFQ

Cas No.:

Product Name:

Quantity:

Please select Metric Ton KG G Pound L ML

Email:

Company name:

Valid Period:

Detailed Requirements:

• Sample
• MOQ
• GMP
• FDA
• Price
• Urgent purchase

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

Remove

Submit

1

What can I do for you?
Get Best Price

Get Best Price for 179116-05-3 Carbamic acid, (3-hydroxy-1,2-dimethylpropyl)-, 1,1-dimethylethyl ester,

Send

Send

Metric Ton KG G Pound L ML

Send

Send